$FLNA

$0.61 -$0.02 (3.73%) Close

$FLNA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 48.3M shares outstanding

Who owns FLNA?

By type of holder

Institutions 25.6% Insiders 2.9% Everyone else 71.5%

Concentration Top 10 holders own 22.1%

Marshall Wace, LLP 3.3% · Two Sigma Investments, LP 3.5%

Institutional ownership

25.6%

-2.6 pts vs last qtr

Institutional holders

-17 vs last qtr

Net shares bought

−1.3M

by institutions in Q2 2026

New / sold out

7 / 24

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Goldman Sachs Group Inc +627.5K
Squarepoint Ops LLC NEW +318.4K

Biggest sellers in Q2 2026

Susquehanna International Group, LLP SOLD OUT −447.3K
Marshall Wace, LLP −415.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Filana Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+20.1%

+6.31% a year

Each share's claim on the business

−16.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $42.5M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years46% 3–5 years1% 1–3 years32% Under 1 year21%

Quarterly turnover

15.5%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting FLNA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MW Marshall Wace, LLP	1.6M	3.31%	−415.0K (−20.6%)	2025	0.0%
Shares held by quarter Peak holding2.1M (Q4'25) Change over 8 quarters+1.6M Share of the company3.310% Marshall Wace, LLP's full portfolio →
TS Two Sigma Investments, LP	1.7M	3.54%	−277.5K (−14.0%)	2024	0.0%
Shares held by quarter Peak holding2.0M (Q1'26) Change over 8 quarters+1.6M Share of the company3.540% Two Sigma Investments, LP's full portfolio →

Marshall Wace, LLP

1.6M

% of company

3.31%

Change vs last qtr

−415.0K (−20.6%)

Held since

2025

Two Sigma Investments, LP

1.7M

% of company

3.54%

Change vs last qtr

−277.5K (−14.0%)

Held since

2024

28 more super investors behind a free account

See every manager holding Filana Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting FLNA on Form N-PORT; together they hold 6.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$1.63M	1.4M	2.83%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$671K	563.9K	1.17%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$1.63M

% of company

2.83%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$671K

% of company

1.17%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Filana Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BR Barry Richard Insider	1.3M	2.77%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.770% Barry Richard's insider activity →
SE Schoen Eric Insider	38.8K	0.08%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.080% Schoen Eric's insider activity →

Barry Richard

Insider

1.3M

% of company

2.77%

Change vs last qtr

—

Held since

—

Schoen Eric

Insider

38.8K

% of company

0.08%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Filana Therapeutics, Inc..

Comments